Purdue University
Fatimah Alhurayri, PharmD, MSc, is a PhD Candidate in the Clinical Pharmaceutical Sciences Program at Purdue University College of Pharmacy. Her research focuses on enhancing medication safety in cancer patients, with a particular emphasis on drug-drug interactions and cardiac toxicities, including QT interval prolongation. She works in close collaboration with researchers at Purdue University and Indiana University to evaluate clinically significant DDIs and develop a cancer-specific QT risk score to identify patients at higher risk and support safer use of cancer therapies. A scholarship from Imam Abdulrahman Bin Faisal University in Saudi Arabia fully funds her PhD studies. She is dedicated to advancing pharmacy education and contributing to improved patient care in her home country.